|
13-102-100 |
HIV-1 anti-p24 gag
|
|
13-103-100 |
HIV-1 anti-p17 gag
|
|
13-104-100 |
HIV-1 anti-gp41 env
|
|
13-105-100 |
HIV-1 anti-gp120 env (aa 307-320)
|
|
13-108-100 |
HIV-1 anti-gp120 env
|
|
13-112-100 |
SIVmac251 anti-p27 gag (does not react w/HIV-1 or -2 proteins)
|
|
13-113-100 |
SIVmac251 anti-p27 gag (cross reacts w/HIV-1 and -2 proteins)
|
|
13-137-100 |
HIV-1 anti-p66/51 pol
|
|
13-138-100 |
HHV-6A Early Protein p41/38
|
|
13-139-001 |
HHV-6A Early Protein p41/38 (cell culture supernatant)
|
|
13-150-100 |
EBV anti-(EA-R) protein p17
|
|
13-152-100 |
HIV-1 anti-nef (aa 35–50)
|
|
13-155-100 |
HIV-1 anti-nef (aa 150–158)
|
|
13-156-100 |
EBV Nuclear Antigen-1 (EBNA-1) MAb
|
|
13-157-100 |
HIV-1 anti-nef (aa 163–173)
|
|
13-160-100 |
HIV-1 anti-nef (aa 195-205)
|
|
13-161-100 |
HIV-1 anti-tat (aa 2–9)
|
|
13-162-100 |
HIV-1 anti-tat (aa 1–16)
|
|
13-167-100 |
HIV-1 anti-rev (aa 33–48)
|
|
13-210-100 |
KSHV/HHV-8 MAb to ORF73 (anti-LNA-1)
|
|
13-211-100 |
KSHV/HHV-8 MAb to ORF59
|
|
13-212-100 |
KSHV/HHV-8 MAb to ORF K8.1 A/B
|
|
13-213-100 |
KSHV/HHV-8 MAb to ORF K8.1 A
|
|
13-216-100 |
HHV-6A/B MAb to early Phosphoprotein p41
|
|
13-217-001 |
HHV-6A MAb to gp82/105 (cell culture supernatant)
|
|
13-218-100 |
HHV-6A/B MAb to gp116/64/54
|
|
13-219-001 |
HHV-6A/B MAb to gp116/64/54 (cell culture supernatant)
|
|
13-223-001 |
HHV-7 MAb (clone KR4) (Ultrafiltered cell culture supernatant)
|
